Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Weight Gain

• A Study of Niacin Regulation
• Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity
• Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine
• Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
• Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant
• Early Metabolic Effects of Dolutegravir or Tenofovir Alefenamide in Healthy Volunteers
• Exenatide for Smoking Cessation and Prevention of Weight Gain
• Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
• Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
• Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery
• L-Carnitine Supplementation, Rate of Weight Gain and EED in Children With SAM
• Arginine + Citrulline as a Supplement for Weight Gain in Fetus With a Decrease in Their Growth Curve
• Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil
• Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
• Can INSTI-associated Weight Gain be Halted or Reversed With a Switch to Doravirine/Lamivudine/Tenofovir DF?
• Doravirine for Persons With Excessive Weight Gain on Integrase Inhibitors and Tenofovir Alafenamide
• Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
• A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain
• Progesterone and Resting Energy Expenditure
• Bioenergetic Effects of Aging and Menopause (BEAM)
• The Effect of CORT118335 on Olanzapine-Induced Weight Gain
• Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin
• This Phase 2, Double Blind, Placebo-controlled, Randomized Study is to Assess the Safety and Efficacy of Miricorilant in Obese Adult With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications.
• A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder
• Oxytocin and Eating
• Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile
• Addressing Post Cessation Weight Gain
• Lorcaserin for Preventing Weight Gain Among Smokers
• Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate
• Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study
• Naltrexone for Antipsychotic-Induced Weight Gain
• 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
• LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression
• Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine
• Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
• Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea
• Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
• Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
• Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics
• Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
• The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
• Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
• Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.
• Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients
• Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects
• Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
• A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
• Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
• FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey
• Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine
• Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
• Effects of Modafinil on Olanzapine Weight Gain
• Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
• Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine
• Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
• Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
• Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
• Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
• Weight Gain Management in Patients With Schizophrenia
• Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia
• A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain
• Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain
• Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment
• Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
• Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine
• Medication, Weight Gain and GI Hormones
• A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain
• A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
• Rosiglitazone-Induced Weight Gain
• Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial
• A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme
• Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
• The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder